scholarly journals Stem cells use in the treatment of neurologic disorders: Has the future already arrived?

2008 ◽  
Vol 65 (6) ◽  
pp. 473-480
Author(s):  
Dragana Obradovic ◽  
Bela Balint ◽  
Evica Dincic ◽  
Ranko Raicevic ◽  
Slobodan Obradovic ◽  
...  

<zakljucak> Buducnost celijske terapije u lecenju neuroloskih bolesti je pocela. Ostaju vazna pitanja na koja odgovor mogu dati samo dobro osmisljene medjunarodne studije, a ticu se vrste celija, nacina njihovog umnozavanja i aplikacije, kao i optimalnog vremenskog okvira za ovakvu vrstu lecenja.

BioTechniques ◽  
2003 ◽  
Vol 35 (6) ◽  
pp. 1232
Author(s):  
Margaret A. Goodell
Keyword(s):  

2021 ◽  
Author(s):  
Moataz Dowaidar

Mesenchymal stem cells (MSCs) have been a new research focus for cancer treatment. Future cancer sufferers will considerably profit from their use in the future. Tumor-directed migratory and integration capacities of MSCs are exceptional, making them potential carriers for the delivery of anticancer medicines, notably cytokines. Their usage in the clinic has lasted around 10 years. The use of mesenchymal stem cells (MSCs) to create successful cancer treatments has been demonstrated in everything from animal models to human studies.


Sign in / Sign up

Export Citation Format

Share Document